This study is currently not accepting new patients, but might later
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Summary
- Location
- at UCLA UCSD UCSF
- Dates
- study started
Description
Summary
Details
Keywords
Eligibility
Locations
Details
- Status
- currently not accepting new patients, but might later
- Start Date
- Sponsor
- Loxo Oncology, Inc.
- ID
- NCT03906331
- Study Type
- Expanded Access
- Last Updated